Skip to main content
SESODA logo

SESODA — Investor Relations & Filings

Ticker · 1708 ISIN · TW0001708006 TW Manufacturing
Filings indexed 1,685 across all filing types
Latest filing 2026-03-12 Regulatory Filings
Country TW Taiwan
Listing TW 1708

About SESODA

www.sesoda.com.tw

Sesoda Corporation specializes in the production and distribution of fertilizers and inorganic chemical products. As a leading manufacturer of Potassium Sulfate (SOP), the company maintains an annual production capacity of 140,000 tons, offering both powder and granular varieties. Its core product portfolio includes Soda Ash, Sodium Bicarbonate, Hydrochloric Acid, Calcium Chloride, and Monocalcium Phosphate, serving applications in agriculture, glass manufacturing, food processing, and industrial cleaning. The company’s premium SOP is a low-chlorine fertilizer essential for high-value crops and hydroponics. With over 90% of its SOP output exported to international markets, the company maintains a significant global footprint. Operations emphasize environmental sustainability, converting by-products into value-added chemicals. Diversified interests also include bulk shipping and food services.

Recent filings

Filing Released Lang Actions
公告本公司114年度合併財務報告業經董事會通過
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (1708 東鹼) reporting that its consolidated financial report for the fiscal year 114 (covering 114/01/01 to 114/12/31) has been approved by the board of directors and audit committee on 115/03/12. It includes summarized financial data such as revenue, gross profit, operating profit, net profit, EPS, total assets, liabilities, and equity. The document length is short (913 characters) and it primarily serves as an announcement of the approval of the annual consolidated financial report rather than the full report itself. There is no detailed financial statement or comprehensive analysis present. According to the "Menu vs Meal" rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback for such announcements that do not contain the full report.
2026-03-12 Chinese
115年2月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (東鹼) providing details about fund lending balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. It is a regulatory disclosure of financial guarantees and related party transactions, but it does not contain comprehensive financial statements or detailed financial analysis. The document is short (624 characters) and appears to be a routine regulatory announcement rather than a full report. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory disclosures that do not fit other categories.
2026-03-06 Chinese
115年2月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 東鹼, presented in a tabular format with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (769 characters) and it does not contain detailed financial statements or comprehensive analysis. It is a brief financial data summary rather than a full report or announcement. Therefore, it fits best as a Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info.
2026-03-06 Chinese
115年02月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings and changes in shareholdings by insiders such as directors, chairpersons, general managers, and other executives. It includes data on shares held, increases, decreases, and trust shares, with specific references to insider identities and their share transactions. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider share transactions and holdings, which aligns with the definition of Director's Dealing (DIRS). The document is lengthy and contains substantive data, not just an announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the appropriate classification is Director's Dealing (DIRS).
2026-03-03 Chinese
115年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It focuses on insider shareholdings and related pledges, with no financial statements or earnings data. The content is consistent with a report on insider share transactions or holdings. Given the nature of the data—personal share transactions and holdings by company directors and executives—this fits the definition of a Director's Dealing report. The document length is 3456 characters, which is relatively short but contains substantive insider shareholding data, not just an announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2026-03-03 Chinese
公告本公司114年第4季財務報告董事會召開日期
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (1708 東鹼) stating the date of the board meeting to be held on 115/03/12 (Taiwan calendar year 115 corresponds to 2026) where the Q4 financial report for year 114 (2025) will be presented or approved. The document does not contain the financial report itself, only the notification of the board meeting date and the expected agenda. The document length is only 529 characters, which is very short and fits the pattern of a Regulatory Filing (RNS) or Report Publication Announcement (RPA). However, since it is announcing the board meeting date for the financial report and not the publication or release of the report itself, it is best classified as a Regulatory Filing (RNS) as it is a general regulatory announcement about the board meeting and financial report schedule, not the report or its publication announcement.
2026-02-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.